Ken Medlock explains why the price of WTI crude collapsed into previously unchartered, negative territory on April 20, 2020, and what to expect next. Read his post in the Baker Institute Blog.
This blog originally appeared in Forbes on April 21, 2020.
President Biden has an opportunity, the author argues, to resurrect the Deferred Action for Parents of Americans and Lawful Permanent Residents (DAPA) program and provide a pathway to legal status for millions of undocumented parents of U.S. citizens and legal permanent residents. This report explores the potential of the DAPA program to impact immigrant families and policy avenues toward its passage.
This brief examines the four economic pillars that are often credited with bolstering Mexico’s economy in 2019 and 2020 to determine how quickly the nation's economy will bounce back from the COVID-19 pandemic.
Tony Payan, Jose Ivan Rodriguez-SanchezApril 9, 2021
A substantial number of Americans remain unprepared for retirement, despite past policy support and tax incentives to enhance retirement income security. Public finance fellow Joyce Beebe reviews recent policy developments and proposals to enhance the retirement savings system.
The U.S. oil, gas and coal industry largely rose and fell based on global economic and energy market conditions rather than federal energy and environmental policies implemented by the Trump administration, write the authors. As the world recovers from the COVID-19 pandemic, they expect markets to continue to shape the future of the oil and gas industry. Read more on the Baker Institute Blog.
Fellow Katharine Neill Harris testified before the U.S. House Judiciary Committee on the failed war on drugs and solutions based on racial justice and harm reduction.
What are Mexico's prospects for immigration, trade and more, after President Andrés Manuel López Obrador's virtual meeting with President Biden? "Mexico will have to do some heavy lifting," predicts Tony Payan, director of the Center for the United States and Mexico.
Health policy experts Kirstin Matthews and Rekha Lakshmanan compare the three COVID-19 vaccines now available from Pfizer, Moderna and Johnson & Johnson and, in a separate infographic, provide an overview of Operation Warp Speed.
Vaccines and other biomedical advances will not be sufficient to halt COVID-19, unless we simultaneously counter anti-science aggression, writes Peter Hotez, fellow in disease and poverty, in a new article for PLOS Biology.